Practical implications for clinical monitoring.
This final article presents the authors' recommendations, based on the findings presented in this publication, for clinical monitoring in patients being treated for mood and psychotic disorders. Suggestions are given for monitoring body weight/body mass index and for screening for type 2 diabetes and lipid abnormalities.
D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis* / Q000209:etiology / Q000523:psychology; D050171:Dyslipidemias / Q000175:diagnosis* / Q000209:etiology / Q000523:psychology; D006801:Humans; D019964:Mood Disorders / Q000150:complications* / Q000378:metabolism / Q000628:therapy; D011159:Population Surveillance; D011618:Psychotic Disorders / Q000150:complications* / Q000378:metabolism / Q000628:therapy